XFOR - X4 Pharmaceuticals Inc

https://www.x4pharma.com

Momentum: Bearish

Recent News

Top 3 Health Care Stocks That May Rocket Higher In April - UnitedHealth Group ( NYSE:UNH ) , Bristol-Myers Squibb ( NYSE:BMY )

Benzinga • 4 months, 2 weeks ago • score: 0.02

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

X4 Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for the treatment of back diseases. The company is headquartered in Boston, Massachusetts.

52W High

$26.82

52W Low

$1.35

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.61

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

1.10

EV/Revenue (<3 favorable)

2.86

P/S (TTM) (<3 favorable)

2.40

P/B (<3 favorable)

19.79

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

8.07%

Institutions (25–75% balanced)

83.45%

Shares Outstanding

22,449,100

Float

8,158,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

32,774,000

Gross Profit (TTM)

27,203,000

EPS (TTM)

-15.14

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

-13.30%

ROE (TTM) (>15% strong)

-2.07%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

2.50

Momentum

Bearish momentum

Value

0.2419

0.2805

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025